Positive staining with antibodies against MDM2 and CDK4 have also shown to be helpful in distinguishing low-grade osteosarcoma from benign fibro-osseous mimics but should be used with caution due to limited specificity (Figure 4C) (26). Here, MDM2 is linked to osteosarcoma.